Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting

Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting

Objective To describe real-world baseline characteristics and patient-reported outcomes (PROs) at 6-month and 12-month follow-up visits among patients with psoriasis who initiated and maintained secukinumab, stratified by prior exposure to biologics. Methods This real-world study included patients e...

Full description

Bibliographic Details
Main Authors: Bruce Strober, Dhaval Patil, Robert R. McLean, Melissa Moore-Clingenpeel, Ning Guo, Eugenia Levi, Mark Lebwohl
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Journal of Dermatological Treatment
Subjects:
psoriasis
secukinumab
patient-reported outcomes
registry
Online Access:http://dx.doi.org/10.1080/09546634.2022.2116266

Internet

http://dx.doi.org/10.1080/09546634.2022.2116266

Similar Items